Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $764.21 | 46 | 85.8% |
| Education | $126.55 | 5 | 14.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $389.41 | 17 | $0 (2018) |
| Allergan Inc. | $152.40 | 9 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $144.59 | 14 | $0 (2018) |
| Vanda Pharmaceuticals Inc. | $107.40 | 6 | $0 (2018) |
| Alkermes, Inc. | $44.32 | 2 | $0 (2018) |
| Lundbeck LLC | $21.33 | 1 | $0 (2018) |
| Neos Therapeutics, LP | $15.90 | 1 | $0 (2018) |
| Neurocrine Biosciences, Inc. | $15.41 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $600.91 | 38 | Otsuka America Pharmaceutical, Inc. ($229.62) |
| 2017 | $289.85 | 13 | Otsuka America Pharmaceutical, Inc. ($159.79) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2018 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Schizophrenia | ||||||
| 12/10/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Education | In-kind items and services | $1.79 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2018 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: NEUROLOGY | ||||||
| 11/12/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $3.73 | General |
| Category: Central Nervous System | ||||||
| 11/05/2018 | Allergan Inc. | VRAYLAR (Drug) | Education | In-kind items and services | $31.50 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2018 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: ADHD | ||||||
| 09/07/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $2.91 | General |
| Category: Central Nervous System | ||||||
| 08/26/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: PSYCHIATRY | ||||||
| 08/13/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $1.91 | General |
| Category: Central Nervous System | ||||||
| 08/06/2018 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Schizophrenia | ||||||
| 06/15/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $2.71 | General |
| Category: Central Nervous System | ||||||
| 06/04/2018 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Schizophrenia | ||||||
| 05/21/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Education | In-kind items and services | $4.52 | General |
| Category: PSYCHIATRY | ||||||
| 05/20/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $4.70 | General |
| Category: PSYCHIATRY | ||||||
| 05/11/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $4.06 | General |
| Category: Central Nervous System | ||||||
| 04/26/2018 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.33 | General |
| Category: PSYCHIATRY | ||||||
| 04/13/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: PSYCHIATRY | ||||||
| 04/09/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $2.46 | General |
| Category: Central Nervous System | ||||||
| 03/31/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Central Nervous System | ||||||
| 03/30/2018 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $85.25 | General |
| 03/26/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $2.58 | General |
| Category: Central Nervous System | ||||||
| 03/19/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $2.45 | General |
| Category: Central Nervous System | ||||||
| 03/12/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $4.99 | General |
| Category: Central Nervous System | ||||||
| 03/02/2018 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Schizophrenia | ||||||
About Dr. Sheila Rowan, M.D
Dr. Sheila Rowan, M.D is a Psychiatry healthcare provider based in Lauderhill, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407953094.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sheila Rowan, M.D has received a total of $890.76 in payments from pharmaceutical and medical device companies, with $600.91 received in 2018. These payments were reported across 51 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($764.21).
Practice Information
- Specialty Psychiatry
- Location Lauderhill, FL
- Active Since 09/17/2006
- Last Updated 03/21/2017
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1407953094
Products in Payments
- REXULTI (Drug) $348.15
- VRAYLAR (Drug) $152.40
- Fanapt (Drug) $107.40
- ABILIFY MAINTENA (Drug) $62.59
- AUSTEDO (Drug) $59.34
- Aristada 441 mg (Drug) $44.32
- Adzenys XR-ODT (Drug) $15.90
- INGREZZA (Drug) $15.41
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.